Skip to main content
Erschienen in: Obesity Surgery 5/2018

09.11.2017 | Original Contributions

Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up

BariScan Study

verfasst von: Felix Nickel, Christian Tapking, Laura Benner, Janina Sollors, Adrian T. Billeter, Hannes G. Kenngott, Loay Bokhary, Mathias Schmid, Moritz von Frankenberg, Lars Fischer, Sebastian Mueller, Beat P. Müller-Stich

Erschienen in: Obesity Surgery | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Bariatric surgery gains attention as a potential treatment for non-alcoholic fatty liver disease (NAFLD). The present study aimed to evaluate improvement of NAFLD after the two most common bariatric procedures with validated non-invasive instruments.

Material and Methods

N = 100 patients scheduled for laparoscopic sleeve gastrectomy (LSG) or Roux-en-Y gastric bypass (RYGB) were included. NAFLD was evaluated preoperatively and postoperatively with liver stiffness measurement by transient elastography and laboratory-based fibrosis scores. Clinical data included body mass index (BMI), total weight loss (%TWL), excess weight loss (%EWL), age, gender, comorbidities, and the Edmonton obesity staging system (EOSS).

Results

There were significant improvements of BMI, %TWL, %EWL, and EOSS after bariatric surgery. Liver stiffness was significantly improved from pre- to postoperative (12.9 ± 10.4 vs. 7.1 ± 3.7 kPa, p < 0.001) at median follow-up of 12.5 months. Additionally, there were significant improvements of liver fibrosis scores (aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio 0.8 ± 0.3 vs. 1.1 ± 0.4, p < 0.001; NAFLD fibrosis score − 1.0 ± 1.8 vs. − 1.7 ± 1.3, p < 0.001; APRI score 0.3 ± 0.2 vs. 0.3 ± 0.1, p = 0.009; BARD score 2.3 ± 1.2 vs. 2.8 ± 1.1, p = 0.008) and laboratory parameters (ALT, AST, and GGT). After adjustment for baseline liver stiffness, RYGB showed higher improvements than LSG, and there was no gender difference. Improvement of liver stiffness was not correlated to improvement of BMI, %TWL, %EWL, or EOSS.

Conclusions

NAFLD seems to be improved by bariatric surgery as measured by validated non-invasive instruments. Furthermore, it appears that RYGB is more effective than LSG. No correlation could be detected between NAFLD and weight loss. The present study highlights the potential of bariatric surgery for successful treatment of NAFLD. Further research is required to understand the exact mechanisms.
Literatur
1.
Zurück zum Zitat Ng M. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;386(9945):766–81.CrossRef Ng M. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;386(9945):766–81.CrossRef
3.
Zurück zum Zitat Huang Z et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med. 1998;128(2):81–8.CrossRefPubMed Huang Z et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med. 1998;128(2):81–8.CrossRefPubMed
4.
Zurück zum Zitat Sanyal AJ. A technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123(5):1705–25.CrossRefPubMed Sanyal AJ. A technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123(5):1705–25.CrossRefPubMed
5.
Zurück zum Zitat Day CP. Non-alcoholic fatty liver disease: current concepts and management strategies. Clin Med. 2006;6(1):19–25.CrossRef Day CP. Non-alcoholic fatty liver disease: current concepts and management strategies. Clin Med. 2006;6(1):19–25.CrossRef
6.
Zurück zum Zitat Charlton MR et al. Frequency of outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141(4):1249–53.CrossRefPubMed Charlton MR et al. Frequency of outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141(4):1249–53.CrossRefPubMed
7.
Zurück zum Zitat Agopian VG et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg. 2012;256(4):624–33.CrossRefPubMed Agopian VG et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg. 2012;256(4):624–33.CrossRefPubMed
8.
Zurück zum Zitat Belli LS et al. Impact of direct anti-viral agents on inactivation/delisting of liver transplant candidates listed for decompensated C cirrhosis: a European study. In: International Liver Congress (ILC): abstract PS036; 2016. Belli LS et al. Impact of direct anti-viral agents on inactivation/delisting of liver transplant candidates listed for decompensated C cirrhosis: a European study. In: International Liver Congress (ILC): abstract PS036; 2016.
10.
Zurück zum Zitat Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology. 1990;99(5):1408–13.CrossRefPubMed Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology. 1990;99(5):1408–13.CrossRefPubMed
11.
Zurück zum Zitat Park HS, Kim MW, Shin ES. Effect of weight control on hepatic abnormalities in obese patients with fatty liver. Kor Med Sci. 1995;10(6):414–21.CrossRef Park HS, Kim MW, Shin ES. Effect of weight control on hepatic abnormalities in obese patients with fatty liver. Kor Med Sci. 1995;10(6):414–21.CrossRef
12.
Zurück zum Zitat Ueno T, Sugawara H, Sujaku K. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver disease. J Hepatol. 1997;27(1):103–7.CrossRefPubMed Ueno T, Sugawara H, Sujaku K. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver disease. J Hepatol. 1997;27(1):103–7.CrossRefPubMed
13.
Zurück zum Zitat Sjöström L et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.CrossRefPubMed Sjöström L et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.CrossRefPubMed
14.
Zurück zum Zitat Nickel F et al. Gastrointestinal quality of life improves significantly after sleeve gastrectomy and Roux-en-Y gastric bypass-a prospective cross-sectional study within a 2-year follow-up. Obes Surg. 2017;27(5):1292–7.CrossRefPubMed Nickel F et al. Gastrointestinal quality of life improves significantly after sleeve gastrectomy and Roux-en-Y gastric bypass-a prospective cross-sectional study within a 2-year follow-up. Obes Surg. 2017;27(5):1292–7.CrossRefPubMed
15.
Zurück zum Zitat Nickel F et al. Influence of bariatric surgery on quality of life, body image, and general self-efficacy within 6 and 24 months-a prospective cohort study. Surg Obes Relat Dis. 2017;12(2):313–9.CrossRef Nickel F et al. Influence of bariatric surgery on quality of life, body image, and general self-efficacy within 6 and 24 months-a prospective cohort study. Surg Obes Relat Dis. 2017;12(2):313–9.CrossRef
16.
Zurück zum Zitat Echosens. FibroScan® user manual. Paris: Frankreich; 2015. Echosens. FibroScan® user manual. Paris: Frankreich; 2015.
17.
Zurück zum Zitat Sandrin L et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705–13.CrossRefPubMed Sandrin L et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705–13.CrossRefPubMed
19.
Zurück zum Zitat Boursier K, Konaté A, Gorea G. Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin Gastroenterol Hepatol. 2008;6(11):1263–9.CrossRefPubMed Boursier K, Konaté A, Gorea G. Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin Gastroenterol Hepatol. 2008;6(11):1263–9.CrossRefPubMed
20.
Zurück zum Zitat Castéra L et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128(2):343–50.CrossRefPubMed Castéra L et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128(2):343–50.CrossRefPubMed
21.
Zurück zum Zitat Cichoz-Lach H. The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease. Med Sci Monit. 2012;18(12):735–40.CrossRef Cichoz-Lach H. The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease. Med Sci Monit. 2012;18(12):735–40.CrossRef
23.
Zurück zum Zitat Wai CT. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518–26.CrossRefPubMed Wai CT. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518–26.CrossRefPubMed
24.
Zurück zum Zitat R Core Team, A language and environment for statistical computing, R.C. Team, Editor 2015, R Foundation for Statistical Computing, Vienna, Austria. R Core Team, A language and environment for statistical computing, R.C. Team, Editor 2015, R Foundation for Statistical Computing, Vienna, Austria.
25.
Zurück zum Zitat Luger M et al. Prevalence of liver fibrosis and its association with non-invasive fibrosis and metabolic markers in morbidly obese patients with vitamin D deficiency. Obes Surg. 2016; Luger M et al. Prevalence of liver fibrosis and its association with non-invasive fibrosis and metabolic markers in morbidly obese patients with vitamin D deficiency. Obes Surg. 2016;
26.
Zurück zum Zitat Hafeez S, Ahmed MH. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? J Obes. 2013; Hafeez S, Ahmed MH. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? J Obes. 2013;
27.
Zurück zum Zitat Mummadi RR et al. Effects of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6(12):1396–402.CrossRefPubMed Mummadi RR et al. Effects of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6(12):1396–402.CrossRefPubMed
28.
Zurück zum Zitat Fischer L et al. BariSurg trial: sleeve gastrectomy versus Roux-en-Y gastric bypass in obese patients with BMI 35–60 kg/m2—a multi-centre randomized patient and observer blind non-inferiority trial. BMC Surg. 2015;15(1):87.CrossRefPubMedPubMedCentral Fischer L et al. BariSurg trial: sleeve gastrectomy versus Roux-en-Y gastric bypass in obese patients with BMI 35–60 kg/m2—a multi-centre randomized patient and observer blind non-inferiority trial. BMC Surg. 2015;15(1):87.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Algooneh A et al. Non-alcoholic fatty liver disease resolution following sleeve gastrectomy. Surg Endosc. 2016;30(5):1983–7.CrossRefPubMed Algooneh A et al. Non-alcoholic fatty liver disease resolution following sleeve gastrectomy. Surg Endosc. 2016;30(5):1983–7.CrossRefPubMed
30.
Zurück zum Zitat Naveau S et al. The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. Obes Surg. 2014;24(10):1693–701.CrossRefPubMed Naveau S et al. The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. Obes Surg. 2014;24(10):1693–701.CrossRefPubMed
31.
Zurück zum Zitat Müller-Stich BP et al. Gastric bypass leads to improvement of diabetic neuropathy independent of glucose normalization—results of a prospective cohort study (DiaSurg 1 study). Ann Surg. 2013;258(5):760–5.CrossRefPubMed Müller-Stich BP et al. Gastric bypass leads to improvement of diabetic neuropathy independent of glucose normalization—results of a prospective cohort study (DiaSurg 1 study). Ann Surg. 2013;258(5):760–5.CrossRefPubMed
32.
Zurück zum Zitat Kenngott HG et al. DiaSurg 2 trial—surgical vs. medical treatment of insulin-dependent type 2 diabetes mellitus in patients with a body mass index between 26 and 35 kg/m2: study protocol of a randomized controlled multicenter trial—DRKS00004550. Trials. 2013;14(183) Kenngott HG et al. DiaSurg 2 trial—surgical vs. medical treatment of insulin-dependent type 2 diabetes mellitus in patients with a body mass index between 26 and 35 kg/m2: study protocol of a randomized controlled multicenter trial—DRKS00004550. Trials. 2013;14(183)
33.
Zurück zum Zitat Chalasani N et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and American Gastroenterological Association. Hepatology. 2012;55(6):2005–23.CrossRefPubMed Chalasani N et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and American Gastroenterological Association. Hepatology. 2012;55(6):2005–23.CrossRefPubMed
34.
Zurück zum Zitat Aguilar-Olivos NE et al. The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome. Metabolism. 2016;65(8):1196–207.CrossRefPubMed Aguilar-Olivos NE et al. The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome. Metabolism. 2016;65(8):1196–207.CrossRefPubMed
35.
Zurück zum Zitat Taitano A, Markow M, Finan J. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointestinal Surg. 2015;19(3):429–37.CrossRef Taitano A, Markow M, Finan J. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointestinal Surg. 2015;19(3):429–37.CrossRef
37.
Zurück zum Zitat Billeter AT et al. Combined non-alcoholic fatty liver disease and type 2 diabetes mellitus: sleeve gastrectomy or gastric bypass?—a controlled matched pair study of 34 patients. Obes Surg. 2016;26(8):1867–74.CrossRefPubMed Billeter AT et al. Combined non-alcoholic fatty liver disease and type 2 diabetes mellitus: sleeve gastrectomy or gastric bypass?—a controlled matched pair study of 34 patients. Obes Surg. 2016;26(8):1867–74.CrossRefPubMed
38.
Zurück zum Zitat Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98(5):960–7.CrossRefPubMed Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98(5):960–7.CrossRefPubMed
39.
Zurück zum Zitat Torgerson JS et al. Are elevated aminotransferases and decreased bilirubin additional characteristics of the metabolic syndrome? Obes Res. 1997;5(2):105–14.CrossRefPubMed Torgerson JS et al. Are elevated aminotransferases and decreased bilirubin additional characteristics of the metabolic syndrome? Obes Res. 1997;5(2):105–14.CrossRefPubMed
40.
Zurück zum Zitat Ekstedt M et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44(865–873) Ekstedt M et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44(865–873)
41.
Zurück zum Zitat Burza MA et al. Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. PLoS One. 2013;8(3) Burza MA et al. Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. PLoS One. 2013;8(3)
42.
Zurück zum Zitat Nascimento TM et al. Comparison of hepatic profile in pre and postoperative of bariatric surgery: private vs public network. Arg Bras Cir Dig. 2015;28(4):274–7.CrossRef Nascimento TM et al. Comparison of hepatic profile in pre and postoperative of bariatric surgery: private vs public network. Arg Bras Cir Dig. 2015;28(4):274–7.CrossRef
43.
Zurück zum Zitat Giannini EG et al. A simple approach to noninvasively identifying significant fibrosis in chronic hepatitis C patients in clinical practice. J Clin Gastroenterol. 2006;40(6):521–7.CrossRefPubMed Giannini EG et al. A simple approach to noninvasively identifying significant fibrosis in chronic hepatitis C patients in clinical practice. J Clin Gastroenterol. 2006;40(6):521–7.CrossRefPubMed
44.
Zurück zum Zitat Vallet-Pichard A et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32–6.CrossRefPubMed Vallet-Pichard A et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32–6.CrossRefPubMed
45.
46.
Zurück zum Zitat Foucher J et al. Prevalence of factors associated with failure liver stiffness measurement using Fibroscan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol. 2006;18(4):411–2.CrossRefPubMed Foucher J et al. Prevalence of factors associated with failure liver stiffness measurement using Fibroscan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol. 2006;18(4):411–2.CrossRefPubMed
47.
Zurück zum Zitat Sandrin L, Fourquet B, Hasquenoph JM. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705–13.CrossRefPubMed Sandrin L, Fourquet B, Hasquenoph JM. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705–13.CrossRefPubMed
48.
Zurück zum Zitat Scott DR, Levy MT. Liver transient elastography (Fibroscan): a place in the management algorithms of chronic viral hepatitis. Antivir Ther. 2010;15(1):1–11.CrossRefPubMed Scott DR, Levy MT. Liver transient elastography (Fibroscan): a place in the management algorithms of chronic viral hepatitis. Antivir Ther. 2010;15(1):1–11.CrossRefPubMed
49.
Zurück zum Zitat Wong GL et al. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. Clin Gastroenterol Hepatol. 2008;6(9):1027–35.CrossRefPubMed Wong GL et al. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. Clin Gastroenterol Hepatol. 2008;6(9):1027–35.CrossRefPubMed
50.
Zurück zum Zitat Desai NK et al. Comparison of controlled attenuation parameter and liver biopsy to assess hepatic steatosis in pediatric patients. J Pediatr. 2016;173:160–3.CrossRefPubMedPubMedCentral Desai NK et al. Comparison of controlled attenuation parameter and liver biopsy to assess hepatic steatosis in pediatric patients. J Pediatr. 2016;173:160–3.CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Pfeifer L et al. Prospective evaluation of acoustic radiation force impulse (ARFI) elastography and high-frequency B-mode ultrasound in compensated patients for the diagnosis of liver fibrosis/cirrhosis in comparison to mini-laparoscopic biopsy. Ultraschall Med. 2015;36(6):581–9.CrossRefPubMed Pfeifer L et al. Prospective evaluation of acoustic radiation force impulse (ARFI) elastography and high-frequency B-mode ultrasound in compensated patients for the diagnosis of liver fibrosis/cirrhosis in comparison to mini-laparoscopic biopsy. Ultraschall Med. 2015;36(6):581–9.CrossRefPubMed
Metadaten
Titel
Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up
BariScan Study
verfasst von
Felix Nickel
Christian Tapking
Laura Benner
Janina Sollors
Adrian T. Billeter
Hannes G. Kenngott
Loay Bokhary
Mathias Schmid
Moritz von Frankenberg
Lars Fischer
Sebastian Mueller
Beat P. Müller-Stich
Publikationsdatum
09.11.2017
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 5/2018
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-017-3012-z

Weitere Artikel der Ausgabe 5/2018

Obesity Surgery 5/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.